Table of Contents 1 Anti-tuberculosis Therapeutics Market Overview 1.1 Product Overview and Scope of Anti-tuberculosis Therapeutics 1.2 Classification of Anti-tuberculosis Therapeutics by Types 1.2.1 Global Anti-tuberculosis Therapeutics Revenue Comparison by Types (2019-2024) 1.2.2 Global Anti-tuberculosis Therapeutics Revenue Market Share by Types in 2018 1.2.3 Isoniazid 1.2.4 Rifampin 1.2.5 Ethambutol 1.2.6 Pyrazinamide 1.2.7 Otherr 1.3 Global Anti-tuberculosis Therapeutics Market by Application 1.3.1 Global Anti-tuberculosis Therapeutics Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Hospitals and Clinics 1.3.3 Government Agencies 1.3.4 Non-Profit Organizations 1.3.5 Others 1.4 Global Anti-tuberculosis Therapeutics Market by Regions 1.4.1 Global Anti-tuberculosis Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Anti-tuberculosis Therapeutics Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Anti-tuberculosis Therapeutics Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anti-tuberculosis Therapeutics Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Anti-tuberculosis Therapeutics Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anti-tuberculosis Therapeutics Status and Prospect (2014-2024) 1.5 Global Market Size of Anti-tuberculosis Therapeutics (2014-2024) 2 Company Profiles 2.1 Lupin 2.1.1 Business Overview 2.1.2 Anti-tuberculosis Therapeutics Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Lupin Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.2 AstraZeneca 2.2.1 Business Overview 2.2.2 Anti-tuberculosis Therapeutics Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 AstraZeneca Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.3 Johnson & Johnson 2.3.1 Business Overview 2.3.2 Anti-tuberculosis Therapeutics Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Johnson & Johnson Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.4 Macleods Pharmaceuticals 2.4.1 Business Overview 2.4.2 Anti-tuberculosis Therapeutics Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.5 Abbott 2.5.1 Business Overview 2.5.2 Anti-tuberculosis Therapeutics Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Abbott Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.6 Otsuka Pharmaceutical 2.6.1 Business Overview 2.6.2 Anti-tuberculosis Therapeutics Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.7 Eli Lilly 2.7.1 Business Overview 2.7.2 Anti-tuberculosis Therapeutics Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Eli Lilly Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.8 Novartis 2.8.1 Business Overview 2.8.2 Anti-tuberculosis Therapeutics Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Novartis Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.9 Pfizer 2.9.1 Business Overview 2.9.2 Anti-tuberculosis Therapeutics Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Pfizer Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.10 Bayer 2.10.1 Business Overview 2.10.2 Anti-tuberculosis Therapeutics Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Bayer Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.11 GlaxoSmithKline 2.11.1 Business Overview 2.11.2 Anti-tuberculosis Therapeutics Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 GlaxoSmithKline Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.12 Merck 2.12.1 Business Overview 2.12.2 Anti-tuberculosis Therapeutics Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Merck Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.13 Sanofi 2.13.1 Business Overview 2.13.2 Anti-tuberculosis Therapeutics Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 Sanofi Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 3 Global Anti-tuberculosis Therapeutics Market Competition, by Players 3.1 Global Anti-tuberculosis Therapeutics Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Anti-tuberculosis Therapeutics Players Market Share 3.2.2 Top 10 Anti-tuberculosis Therapeutics Players Market Share 3.3 Market Competition Trend 4 Global Anti-tuberculosis Therapeutics Market Size by Regions 4.1 Global Anti-tuberculosis Therapeutics Revenue and Market Share by Regions 4.2 North America Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 4.3 Europe Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 4.5 South America Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 5 North America Anti-tuberculosis Therapeutics Revenue by Countries 5.1 North America Anti-tuberculosis Therapeutics Revenue by Countries (2014-2019) 5.2 USA Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 5.3 Canada Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 5.4 Mexico Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 6 Europe Anti-tuberculosis Therapeutics Revenue by Countries 6.1 Europe Anti-tuberculosis Therapeutics Revenue by Countries (2014-2019) 6.2 Germany Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 6.3 UK Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 6.4 France Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 6.5 Russia Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 6.6 Italy Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Anti-tuberculosis Therapeutics Revenue by Countries 7.1 Asia-Pacific Anti-tuberculosis Therapeutics Revenue by Countries (2014-2019) 7.2 China Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 7.3 Japan Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 7.4 Korea Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 7.5 India Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 8 South America Anti-tuberculosis Therapeutics Revenue by Countries 8.1 South America Anti-tuberculosis Therapeutics Revenue by Countries (2014-2019) 8.2 Brazil Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 8.3 Argentina Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 8.4 Colombia Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Anti-tuberculosis Therapeutics by Countries 9.1 Middle East and Africa Anti-tuberculosis Therapeutics Revenue by Countries (2014-2019) 9.2 Saudi Arabia Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 9.3 UAE Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 9.4 Egypt Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 9.5 Nigeria Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 9.6 South Africa Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) 10 Global Anti-tuberculosis Therapeutics Market Segment by Type 10.1 Global Anti-tuberculosis Therapeutics Revenue and Market Share by Type (2014-2019) 10.2 Global Anti-tuberculosis Therapeutics Market Forecast by Type (2019-2024) 10.3 Isoniazid Revenue Growth Rate (2014-2024) 10.4 Rifampin Revenue Growth Rate (2014-2024) 10.5 Ethambutol Revenue Growth Rate (2014-2024) 10.6 Pyrazinamide Revenue Growth Rate (2014-2024) 10.7 Otherr Revenue Growth Rate (2014-2024) 11 Global Anti-tuberculosis Therapeutics Market Segment by Application 11.1 Global Anti-tuberculosis Therapeutics Revenue Market Share by Application (2014-2019) 11.2 Anti-tuberculosis Therapeutics Market Forecast by Application (2019-2024) 11.3 Hospitals and Clinics Revenue Growth (2014-2019) 11.4 Government Agencies Revenue Growth (2014-2019) 11.5 Non-Profit Organizations Revenue Growth (2014-2019) 11.6 Others Revenue Growth (2014-2019) 12 Global Anti-tuberculosis Therapeutics Market Size Forecast (2019-2024) 12.1 Global Anti-tuberculosis Therapeutics Market Size Forecast (2019-2024) 12.2 Global Anti-tuberculosis Therapeutics Market Forecast by Regions (2019-2024) 12.3 North America Anti-tuberculosis Therapeutics Revenue Market Forecast (2019-2024) 12.4 Europe Anti-tuberculosis Therapeutics Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Anti-tuberculosis Therapeutics Revenue Market Forecast (2019-2024) 12.6 South America Anti-tuberculosis Therapeutics Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Anti-tuberculosis Therapeutics Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Anti-tuberculosis Therapeutics Picture Table Product Specifications of Anti-tuberculosis Therapeutics Table Global Anti-tuberculosis Therapeutics and Revenue (Million USD) Market Split by Product Type Figure Global Anti-tuberculosis Therapeutics Revenue Market Share by Types in 2018 Figure Isoniazid Picture Figure Rifampin Picture Figure Ethambutol Picture Figure Pyrazinamide Picture Figure Otherr Picture Table Global Anti-tuberculosis Therapeutics Revenue (Million USD) by Application (2014-2024) Figure Anti-tuberculosis Therapeutics Revenue Market Share by Applications in 2018 Figure Hospitals and Clinics Picture Figure Government Agencies Picture Figure Non-Profit Organizations Picture Figure Others Picture Table Global Market Anti-tuberculosis Therapeutics Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America Anti-tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe Anti-tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific Anti-tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (2014-2024) Figure South America Anti-tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa Anti-tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (2014-2024) Figure Global Anti-tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (2014-2024) Table Lupin Basic Information, Manufacturing Base and Competitors Table Lupin Anti-tuberculosis Therapeutics Type and Applications Table Lupin Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table AstraZeneca Basic Information, Manufacturing Base and Competitors Table AstraZeneca Anti-tuberculosis Therapeutics Type and Applications Table AstraZeneca Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors Table Johnson & Johnson Anti-tuberculosis Therapeutics Type and Applications Table Johnson & Johnson Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Macleods Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Type and Applications Table Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Abbott Basic Information, Manufacturing Base and Competitors Table Abbott Anti-tuberculosis Therapeutics Type and Applications Table Abbott Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors Table Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Type and Applications Table Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Eli Lilly Basic Information, Manufacturing Base and Competitors Table Eli Lilly Anti-tuberculosis Therapeutics Type and Applications Table Eli Lilly Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Novartis Basic Information, Manufacturing Base and Competitors Table Novartis Anti-tuberculosis Therapeutics Type and Applications Table Novartis Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Anti-tuberculosis Therapeutics Type and Applications Table Pfizer Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Bayer Basic Information, Manufacturing Base and Competitors Table Bayer Anti-tuberculosis Therapeutics Type and Applications Table Bayer Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors Table GlaxoSmithKline Anti-tuberculosis Therapeutics Type and Applications Table GlaxoSmithKline Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Merck Basic Information, Manufacturing Base and Competitors Table Merck Anti-tuberculosis Therapeutics Type and Applications Table Merck Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Sanofi Basic Information, Manufacturing Base and Competitors Table Sanofi Anti-tuberculosis Therapeutics Type and Applications Table Sanofi Anti-tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Global Anti-tuberculosis Therapeutics Revenue (Million USD) by Players (2014-2019) Table Global Anti-tuberculosis Therapeutics Revenue Share by Players (2014-2019) Figure Global Anti-tuberculosis Therapeutics Revenue Share by Players in 2017 Figure Global Anti-tuberculosis Therapeutics Revenue Share by Players in 2018 Figure Global Top 5 Players Anti-tuberculosis Therapeutics Revenue Market Share in 2018 Figure Global Top 10 Players Anti-tuberculosis Therapeutics Revenue Market Share in 2018 Figure Global Anti-tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global Anti-tuberculosis Therapeutics Revenue (Million USD) by Regions (2014-2019) Table Global Anti-tuberculosis Therapeutics Revenue Market Share by Regions (2014-2019) Figure Global Anti-tuberculosis Therapeutics Revenue Market Share by Regions (2014-2019) Figure Global Anti-tuberculosis Therapeutics Revenue Market Share by Regions in 2018 Figure North America Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Figure Europe Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Figure Asia-Pacific Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Figure South America Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Figure Middle East and Africa Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Table North America Anti-tuberculosis Therapeutics Revenue by Countries (2014-2019) Table North America Anti-tuberculosis Therapeutics Revenue Market Share by Countries (2014-2019) Figure North America Anti-tuberculosis Therapeutics Revenue Market Share by Countries (2014-2019) Figure North America Anti-tuberculosis Therapeutics Revenue Market Share by Countries in 2018 Figure USA Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Figure Canada Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Figure Mexico Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Table Europe Anti-tuberculosis Therapeutics Revenue (Million USD) by Countries (2014-2019) Figure Europe Anti-tuberculosis Therapeutics Revenue Market Share by Countries (2014-2019) Figure Europe Anti-tuberculosis Therapeutics Revenue Market Share by Countries in 2018 Figure Germany Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Figure UK Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Figure France Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Figure Russia Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Figure Italy Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Table Asia-Pacific Anti-tuberculosis Therapeutics Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific Anti-tuberculosis Therapeutics Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific Anti-tuberculosis Therapeutics Revenue Market Share by Countries in 2018 Figure China Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Figure Japan Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Figure Korea Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Figure India Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Figure Southeast Asia Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Table South America Anti-tuberculosis Therapeutics Revenue by Countries (2014-2019) Table South America Anti-tuberculosis Therapeutics Revenue Market Share by Countries (2014-2019) Figure South America Anti-tuberculosis Therapeutics Revenue Market Share by Countries (2014-2019) Figure South America Anti-tuberculosis Therapeutics Revenue Market Share by Countries in 2018 Figure Brazil Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Figure Argentina Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Figure Colombia Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Table Middle East and Africa Anti-tuberculosis Therapeutics Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa Anti-tuberculosis Therapeutics Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Anti-tuberculosis Therapeutics Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Anti-tuberculosis Therapeutics Revenue Market Share by Countries in 2018 Figure Saudi Arabia Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Figure UAE Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Figure Egypt Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Figure Nigeria Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Figure South Africa Anti-tuberculosis Therapeutics Revenue and Growth Rate (2014-2019) Table Global Anti-tuberculosis Therapeutics Revenue (Million USD) by Type (2014-2019) Table Global Anti-tuberculosis Therapeutics Revenue Share by Type (2014-2019) Figure Global Anti-tuberculosis Therapeutics Revenue Share by Type (2014-2019) Figure Global Anti-tuberculosis Therapeutics Revenue Share by Type in 2018 Table Global Anti-tuberculosis Therapeutics Revenue Forecast by Type (2019-2024) Figure Global Anti-tuberculosis Therapeutics Market Share Forecast by Type (2019-2024) Figure Global Isoniazid Revenue Growth Rate (2014-2019) Figure Global Rifampin Revenue Growth Rate (2014-2019) Figure Global Ethambutol Revenue Growth Rate (2014-2019) Figure Global Pyrazinamide Revenue Growth Rate (2014-2019) Figure Global Otherr Revenue Growth Rate (2014-2019) Table Global Anti-tuberculosis Therapeutics Revenue by Application (2014-2019) Table Global Anti-tuberculosis Therapeutics Revenue Share by Application (2014-2019) Figure Global Anti-tuberculosis Therapeutics Revenue Share by Application (2014-2019) Figure Global Anti-tuberculosis Therapeutics Revenue Share by Application in 2018 Table Global Anti-tuberculosis Therapeutics Revenue Forecast by Application (2019-2024) Figure Global Anti-tuberculosis Therapeutics Market Share Forecast by Application (2019-2024) Figure Global Hospitals and Clinics Revenue Growth Rate (2014-2019) Figure Global Government Agencies Revenue Growth Rate (2014-2019) Figure Global Non-Profit Organizations Revenue Growth Rate (2014-2019) Figure Global Others Revenue Growth Rate (2014-2019) Figure Global Anti-tuberculosis Therapeutics Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global Anti-tuberculosis Therapeutics Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global Anti-tuberculosis Therapeutics Revenue Market Share Forecast by Regions (2019-2024) Figure North America Anti-tuberculosis Therapeutics Revenue Market Forecast (2019-2024) Figure Europe Anti-tuberculosis Therapeutics Revenue Market Forecast (2019-2024) Figure Asia-Pacific Anti-tuberculosis Therapeutics Revenue Market Forecast (2019-2024) Figure South America Anti-tuberculosis Therapeutics Revenue Market Forecast (2019-2024) Figure Middle East and Africa Anti-tuberculosis Therapeutics Revenue Market Forecast (2019-2024)

Lupin AstraZeneca Johnson & Johnson Macleods Pharmaceuticals Abbott Otsuka Pharmaceutical Eli Lilly Novartis Pfizer Bayer GlaxoSmithKline Merck Sanofi